Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
HB YTTRIUM Y-90 IBRITUMOMAB TIUXETAN TX TO 40 MCI (OTHER A9543344) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 30, 2026 , from http://ppman.hank.ai/transparency/procedure/A9543344/by-state?code_type=OTHER
“HB YTTRIUM Y-90 IBRITUMOMAB TIUXETAN TX TO 40 MCI (OTHER A9543344) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/A9543344/by-state?code_type=OTHER. Accessed
June 30, 2026 .
“HB YTTRIUM Y-90 IBRITUMOMAB TIUXETAN TX TO 40 MCI (OTHER A9543344) by State,” HANK Price Transparency ,
accessed June 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/A9543344/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
A9543344 — Hb Yttrium Y-90 Ibritumomab Tiuxetan Tx To 40 Mci
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$117,231
National median
$102,358 – $132,103
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for A9543344 (OTHER), with interquartile range
State Median p25 p75
WA $117,231 $102,358 $132,103